8,703 Matching Annotations
  1. Nov 2021
    1. Benjamin Veness. (2021, November 2). Singapore’s 🇸🇬 Senior Minister of State for Health, Dr Janil Puthucheary, told Parliament on 1 November: “I hope my explanation has helped members understand why although we say we are living with COVID-19, we cannot just open up, and risk having the number of cases shoot up.” [Tweet]. @venessb. https://twitter.com/venessb/status/1455396047765733376

    1. ReconfigBehSci. (2021, November 2). interestingly the Singapore Health Minister also mentions “boosting through mild infections”—A concept that is currently generating much furore in the UK in the wake of the release of the JCVI minutes on child vaxx decisions 1/n [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1455445587910922240

    1. Dr Daya Sharma 😷🥽💨🧼💉💉. (2021, October 30). Some of the UK JCVI deliberations are deeply disturbing, eg arguing against childhood vax so that they can get infected & boost immunity in adults. Also imply that vax doesn’t have an individual benefit! 🤯 How much of this warped thinking is present in Australia? #COVID19Aus https://t.co/o887d2etcW [Tweet]. @DrDayaSharma. https://twitter.com/DrDayaSharma/status/1454418003429183492

    1. Prof. Gavin Yamey MD MPH. (2021, October 30). “Circulation of COVID-19 in childhood could therefore periodically boost immunity in adults through exposure” When I say childhood vax ALSO benefits adults, folx say “you can’t use benefits to adults in your argument!” JCVI uses benefits to adults of letting kids get infected 👀 [Tweet]. @GYamey. https://twitter.com/GYamey/status/1454433823085715461

    1. ReconfigBehSci. (2021, October 30). Does there maybe need to be more distinction between points raised for discussion and any actual decision? Without knowing about votes etc., it’s maybe a bit strong to say ‘JCVI wanted x...’? I’ve sat on many bodies with minutes documenting positions I disagreed with [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1454488759785897987

    1. ReconfigBehSci. (2021, October 30). as the fallout from the JCVI minutes build, it’s worth considering that the corresponding U.S. body ACIP has been live streaming its meetings on YouTube... Transparency helps reduce faulty reasoning...we should have learned that lesson with the very first lockdown, no? [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1454502337368764421

    1. 𝚃𝚘𝚖 𝙻𝚊𝚠𝚝𝚘𝚗 💙. (2021, October 30). From the paper—Ventilation makes a big difference further away, but below 1-1.5m then you’d have to be in a gale to be safe! ✅DISTANCE if you can ✅VENTILATE - works even within 2m, but sadly not so much within 1-1.5m ✅PPE if you have to get close #COVIDisAirborne https://t.co/wYuWdG47He [Tweet]. @LawtonTri. https://twitter.com/LawtonTri/status/1454355692593328132

    1. Dr. Thomas Wilckens. (2021, October 31). JCVI facing calls from within for greater transparency over decision-making https://buff.ly/3GwVqCZ JCVI has been criticised for failing to publish detailed minutes, modelling and analysis behind its decision to advise vaccinating all over-16s in Britain #covid19 #coronavirus https://t.co/nWbnvci7LI [Tweet]. @Thomas_Wilckens. https://twitter.com/Thomas_Wilckens/status/1454798820156530689

    1. Deepti Gurdasani. (2021, November 1). No- the statement explicitly talks about infection in children being a ‘booster’ to adults i.e. Children infecting adults to protect them against... Infection!🤔 I don’t think there’s any level of cognitive gymnastics that could justify this or make sense of it. [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1455106192112500736

  2. Oct 2021
    1. Singanayagam, A., Hakki, S., Dunning, J., Madon, K. J., Crone, M. A., Koycheva, A., Derqui-Fernandez, N., Barnett, J. L., Whitfield, M. G., Varro, R., Charlett, A., Kundu, R., Fenn, J., Cutajar, J., Quinn, V., Conibear, E., Barclay, W., Freemont, P. S., Taylor, G. P., … Lackenby, A. (2021). Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00648-4

    1. Sun, W., Liu, Y., Amanat, F., González-Domínguez, I., McCroskery, S., Slamanig, S., Coughlan, L., Rosado, V., Lemus, N., Jangra, S., Rathnasinghe, R., Schotsaert, M., Martinez, J. L., Sano, K., Mena, I., Innis, B. L., Wirachwong, P., Thai, D. H., Oliveira, R. D. N., … Palese, P. (2021). A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses. Nature Communications, 12(1), 6197. https://doi.org/10.1038/s41467-021-26499-y

    1. Jeong, M., Ocwieja, K. E., Han, D., Wackym, P. A., Zhang, Y., Brown, A., Moncada, C., Vambutas, A., Kanne, T., Crain, R., Siegel, N., Leger, V., Santos, F., Welling, D. B., Gehrke, L., & Stankovic, K. M. (2021). Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Communications Medicine, 1(1), 1–14. https://doi.org/10.1038/s43856-021-00044-w

    1. Andreano, E., Paciello, I., Piccini, G., Manganaro, N., Pileri, P., Hyseni, I., Leonardi, M., Pantano, E., Abbiento, V., Benincasa, L., Giglioli, G., De Santi, C., Fabbiani, M., Rancan, I., Tumbarello, M., Montagnani, F., Sala, C., Montomoli, E., & Rappuoli, R. (2021). Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature, 1–7. https://doi.org/10.1038/s41586-021-04117-7

    1. Tartof, S. Y., Slezak, J. M., Fischer, H., Hong, V., Ackerson, B. K., Ranasinghe, O. N., Frankland, T. B., Ogun, O. A., Zamparo, J. M., Gray, S., Valluri, S. R., Pan, K., Angulo, F. J., Jodar, L., & McLaughlin, J. M. (2021). Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. The Lancet, 398(10309), 1407–1416. https://doi.org/10.1016/S0140-6736(21)02183-8

    1. Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., … Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4(10), e2128757. https://doi.org/10.1001/jamanetworkopen.2021.28757

    1. Professor Lucy Easthope. (2021, October 20). WFH really is only for a very privileged few now. Not sure how that can stay a “thing” as an NPI. Too many harms being done by a fractured society where people are thriving by getting other people to bring them stuff/ make them things/ look after their family members for them [Tweet]. @LucyGoBag. https://twitter.com/LucyGoBag/status/1450842213613772802

    1. Hulme, W. J., Williamson, E. J., Green, A., Bhaskaran, K., McDonald, H. I., Rentsch, C. T., Schultze, A., Tazare, J., Curtis, H. J., Walker, A. J., Tomlinson, L., Palmer, T., Horne, E., MacKenna, B., Morton, C. E., Mehrkar, A., Fisher, L., Bacon, S., Evans, D., … Goldacre, B. (2021). Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: A cohort study using OpenSAFELY [Preprint]. Epidemiology. https://doi.org/10.1101/2021.10.13.21264937

    1. UCL Centre for Behaviour Change. (2021, October 12). The CBC Conference 2021 programme has just been released and is packed with thought-provoking talks, international keynote speakers, symposia, and plenty of networking opportunities and social exchanges for delegates. Register now! Http://tinyurl.com/5xwa7c27 #cbcconf2021 https://t.co/9iZqPjEEY6 [Tweet]. @UCLBehaveChange. https://twitter.com/UCLBehaveChange/status/1447860878511157252

    1. Wenzel, J., Lampe, J., Müller-Fielitz, H., Schuster, R., Zille, M., Müller, K., Krohn, M., Körbelin, J., Zhang, L., Özorhan, Ü., Neve, V., Wagner, J. U. G., Bojkova, D., Shumliakivska, M., Jiang, Y., Fähnrich, A., Ott, F., Sencio, V., Robil, C., … Schwaninger, M. (2021). The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nature Neuroscience, 1–12. https://doi.org/10.1038/s41593-021-00926-1

    1. Siddle, K. J., Krasilnikova, L. A., Moreno, G. K., Schaffner, S. F., Vostok, J., Fitzgerald, N. A., Lemieux, J. E., Barkas, N., Loreth, C., Specht, I., Tomkins-Tinch, C. H., Silbert, J., Schaeffer, B., Taylor, B. P., Loftness, B., Johnson, H., Schubert, P. L., Shephard, H. M., Doucette, M., … Sabeti, P. C. (2021). Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts (p. 2021.10.20.21265137). https://doi.org/10.1101/2021.10.20.21265137

    1. Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., Pandey, R., Brown, J., Zhou, J., Goonawardane, N., Mishra, S., Whittaker, C., Mellan, T., Marwal, R., Datta, M., … Gupta, R. K. (2021). SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature, 1–6. https://doi.org/10.1038/s41586-021-03944-y

    1. Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, U., Shoai, M., Reynolds, R. H., Botia, J. A., Brookes, K. J., Guetta-Baranes, T., Bellou, E., Bayram, S., Sokolova, D., Ryten, M., Sala Frigerio, C., Escott-Price, V., Morgan, K., Pocock, J. M., Hardy, J., & Salih, D. A. (2021). A genetic link between risk for Alzheimer’s disease and severe COVID-19 outcomes via the OAS1 gene. Brain, awab337. https://doi.org/10.1093/brain/awab337

    1. Wickenhagen, A., Sugrue, E., Lytras, S., Kuchi, S., Noerenberg, M., Turnbull, M. L., Loney, C., Herder, V., Allan, J., Jarmson, I., Cameron-Ruiz, N., Varjak, M., Pinto, R. M., Lee, J. Y., Iselin, L., Palmalux, N., Stewart, D. G., Swingler, S., Greenwood, E. J. D., … Wilson, S. J. (n.d.). A prenylated dsRNA sensor protects against severe COVID-19. Science, 0(0), eabj3624. https://doi.org/10.1126/science.abj3624

    1. Dr Nisreen Alwan 🌻 on Twitter: “New @ONS #LongCovid estimates published today: 1.1 MILLION (1.7% of the whole UK population). Up from the summer estimate of 1.5%. 211,000 people with daily activities ‘limited a lot’. Greatest % in working age (35-69y). Rising prevalence in 17-24y. A tsunami of chronic illness.” / Twitter. (n.d.). Retrieved October 10, 2021, from https://twitter.com/Dr2NisreenAlwan/status/1446110337753829379

    1. Forbes, H., Morton, C. E., Bacon, S., McDonald, H. I., Minassian, C., Brown, J. P., Rentsch, C. T., Mathur, R., Schultze, A., DeVito, N. J., MacKenna, B., Hulme, W. J., Croker, R., Walker, A. J., Williamson, E. J., Bates, C., Mehrkar, A., Curtis, H. J., Evans, D., … Tomlinson, L. A. (2020). Association between living with children and outcomes from COVID-19: An OpenSAFELY cohort study of 12 million adults in England (p. 2020.11.01.20222315). https://doi.org/10.1101/2020.11.01.20222315